On July 14, 2025, Waters and BD announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters through a tax-efficient Reverse Morris Trust transaction.
Compelling Value Creation Opportunity
Waters and BD Biosciences & Diagnostic Solutions share a rich legacy of innovation, complementary expertise in regulated, high-volume settings, and a deep commitment to science and solving customers’ unmet needs. Together, this combination will create a more diversified company with best-in class technologies, industry-leading financials, and a clear runway for sustainable, long-term growth.”





Comments
Post a Comment